(lp0
S"Here's Who Just Picked Up Genvec Inc.  Shares Small Cap Exclusive  - Feb 17, 2017 For those not familiar with the company, GenVec, Inc.  is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines."
p1
aS'GenVec Inc  Is Another Low Float Runner Insider Financial - Jan 11, 2017 Low floats have been the name of the game for a number of biotech companies this week, with some seemingly inexplicable runs only explained by low float, high-volume spikes.'
p2
aS'GenVec Signs Option Agreement for Gene Editing and Cell Targeting Technology ... PR Newswire  - Jan 5, 2017 GAITHERSBURG, Md., Jan. 5, 2017 /PRNewswire/ -- GenVec, Inc. , a clinical-stage gene delivery company, announced today that it has entered into an exclusive option agreement with Washington University in St. Louis to license&nbsp;...'
p3
aS'Intrexon to acquire fellow Md. biotech Washington Business Journal - Jan 24, 2017 Germantown-based Intrexon Corp. is swallowing up its fellow Montgomery County biotech, GenVec Inc., a small Gaithersburg gene therapy company that has been struggling to grow since its lead cancer drug candidate failed in late-stage trials in 2010.GenVec Inc.  Is Up Sharply After Bought By Intrexon - RTT NewsIntrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform - PR Newswire '
p4
aS'The 10.4% Stake of GenVec Inc  Owned by Mmcap International Inc. Spc Petro Global News 24 - 2 hours ago recently stated that they own a 10.4% stake in GenVec Inc  in a Schedule 13G/A disclosure that was filed with the Securities and Exchange Commission on Tuesday, March 14th.'
p5
aS'6.43 MarketWatch - Dec 21, 2009 GenVec Inc. NASDAQ: GNVC. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p6
aS'GenVec, Inc. , Interview with Doug Swirsky, CEO Nasdaq - Feb 24, 2015 GenVec is a pioneer in the design, testing and manufacture of adenovectored product candidates that can deliver on the promise of gene-based medicine.'
p7
aS'GenVec Inc. GNVC  Wall Street Journal - Feb 12, 2011 News GenVec Inc.GNVC. Significant News Only. 03/01/17; Press Release. Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results.'
p8
aS'GenVec Inc  Given $7.00 Consensus Target Price by Analysts BNB Daily  - Mar 13, 2017 GenVec logo GenVec Inc  has been given a consensus broker rating score of 3.00  from the one analysts that provide coverage for the stock, Zacks Investment Research reports.GenVec, Inc.  Reviewed By Analysts - The De Soto Edge'
p9
aS'GenVec Provides Update on Hearing Loss Clinical Program PR Newswire  - May 2, 2016 GAITHERSBURG, Md., May 2, 2016 /PRNewswire/ -- GenVec, Inc. , a clinical-stage gene delivery company, announced today that it was notified by its collaborator Novartis that the Data Safety Monitoring Board  for the Phase 1/2&nbsp;...'
p10
a.